Masimo Corporation  

(Public, NASDAQ:MASI)   Watch this stock  
Find more results for MASI
41.91
+0.86 (2.10%)
Real-time:   11:36AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 41.05 - 42.25
52 week 19.30 - 42.48
Open 41.16
Vol / Avg. 55,029.00/341,624.00
Mkt cap 2.19B
P/E 32.37
Div/yield     -
EPS 1.29
Shares 52.62M
Beta 0.97
Inst. own 85%
Aug 4, 2015
Q2 2015 Masimo Corp Earnings Call - 4:30PM EDT - Add to calendar
Aug 4, 2015
Q2 2015 Masimo Corp Earnings Release - 4:00PM EDT - Add to calendar
Jun 9, 2015
Masimo Corp at Goldman Sachs Healthcare Conference - Webcast
Jun 2, 2015
Masimo Corp Annual Shareholders Meeting
May 6, 2015
Q1 2015 Masimo Corp Earnings Call - Webcast
May 6, 2015
Q1 2015 Masimo Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '15) 2015
Net profit margin 12.83% 12.68%
Operating margin 17.72% 17.64%
EBITD margin - 18.07%
Return on average assets 13.95% 14.82%
Return on average equity 26.15% 22.93%
Employees 1,200 -
CDP Score - -

Address

52 Discovery
IRVINE, CA 92618-3105
United States - Map
+1-949-2977000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Masimo Corporation is a global medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company's core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and optical gas monitoring. In addition, the Company offers Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system, which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.

Officers and directors

Joe E. Kiani Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Mark P. de Raad Chief Financial Officer, Executive Vice President - Finance
Age: 55
Bio & Compensation  - Reuters
Jon Coleman President - Worldwide Sales, Professional Services and Medical Affairs
Age: 51
Bio & Compensation  - Reuters
Rick Fishel President, Worldwide OEM Business & Blood Management
Age: 57
Bio & Compensation  - Reuters
Anand Sampath Chief Operating Officer
Age: 48
Bio & Compensation  - Reuters
Yongsam Lee Executive Vice President, Chief Information Officer
Age: 50
Bio & Compensation  - Reuters
Tom McClenahan Executive Vice President, General Counsel, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Paul Jansen Executive Vice President - Business Development
Age: 44
Bio & Compensation  - Reuters
David J. Van Ramshorst Chief Accounting Officer
Age: 54
Bio & Compensation  - Reuters
Steven J. Barker M.D., Ph.D. Director
Age: 70
Bio & Compensation  - Reuters